[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Inc. (ALNY) added to Nasdaq XXX Index; company repurchases $XXXX million in convertible notes.

### About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics.  
Alnylam Pharmaceuticals, Inc. uses the ticker $ALNY for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Alnylam Pharmaceuticals, Inc. (ALNY) trading volume is up XXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) social dominance is up XXXXXX% from the previous week.
- Alnylam Pharmaceuticals, Inc. (ALNY) Galaxy Score™ is up XXXXXX% from the previous X months.
- Alnylam Pharmaceuticals, Inc. (ALNY) engagements is up XXXXXX% from the previous week.

### Price: $XXXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/close.tsv)  
The stock price is experiencing volatility due to mixed news, with positive clinical trial data and strong sales being offset by regulatory concerns and negative social media sentiment, leading to a balanced outlook.  

24-Hour: -XXXX%
7-Day: -XXXXX%
30-Day: -XXXXX%

1-Year High: $XXXXXX on 2025-10-20  
1-Year Low: $XXXXXX on 2025-04-08  
  
  
### AltRank: XXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/alt_rank.tsv)  
Alnylam Pharmaceuticals, Inc. (ALNY) is currently AltRank #642 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXX -XXX  
X Month: XXX -XXX  
X Months: XXX -XX  
X Year: XXX -XXX  
1-Year High: XXXXX on 2025-06-26  
1-Year Low: X on 2025-03-22  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX +44  
X Month: XX +6  
X Months: XX +4  
X Year: XX -XX  
1-Year High: XX on 2025-02-19  
1-Year Low: XX on 2025-06-26  
  
  
### Engagements: XXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/interactions.tsv)  
Current Value: XXXXXX  
Daily Average: XXXXXX  
X Week: XXXXXX +333%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXX +15%  
X Year: XXXXXXXXX -XX%  
1-Year High: XXXXXXX on 2025-03-21  
1-Year Low: XXX on 2025-12-07  

Engagements by network (24h):
TikTok: XXXXX
X: XXXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XXX  
X Week: XXX +7.40%  
X Month: XXX -XX%  
X Months: XXXXX +21%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2025-08-13  
1-Year Low: XX on 2025-12-07  

Mentions by network (24h):
TikTok: XX
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Alnylam Pharmaceuticals, Inc. (ALNY) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XXX  
X Week: XXX +0.61%  
X Month: XXX -XXXX%  
X Months: XXXXX +106%  
X Year: XXXXX +58%  
1-Year High: XXX on 2025-06-28  
1-Year Low: XX on 2025-12-07  

The most influential creators that mention Alnylam Pharmaceuticals, Inc. in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BioBoyScout](/creator/twitter/BioBoyScout)         | X    | XXXXX     | X     | XXX         |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | X    | XXXXX     | X     | XXX         |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXX         |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)         | X    | XXXXXX    | X     | XX          |
| [@StockCompil](/creator/twitter/StockCompil)         | X    | XXXXX     | X     | XX          |
| [@Biobeats99](/creator/twitter/Biobeats99)           | X    | XXX       | X     | XX          |
| [@ElliottForecast](/creator/twitter/ElliottForecast) | X    | XXXXXX    | X     | XX          |
| [@DanzTrader](/creator/twitter/DanzTrader)           | X    | XXXXX     | X     | XX          |
| [@USCorpFilings](/creator/twitter/USCorpFilings)     | X    | XXXXX     | X     | XX          |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | XX   | XXXXX     | X     | XX          |

[View More](/list/creators/alnylam-pharmaceuticals-inc/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% no change  
X Month: XX% -X%  
X Months: XX% +13%  
X Year: XX% -X%  
1-Year High: XXX% on 2025-07-29  
1-Year Low: XX% on 2025-12-02  

Most Supportive Themes:
- Positive Data from HELIOS-B Study: (35%) New data from the HELIOS-B Phase X study shows reduced gastrointestinal events in ATTR-CM patients treated with Vutrisiran, supporting its use as a first-line therapy.
- Amvuttra Sales and Revenue Guidance: (20%) Alnylam reported strong Amvuttra sales and increased its 2025 revenue guidance, indicating positive financial performance.
- First Patient Dosed in ZENITH Trial: (15%) Alnylam announced the first patient has been dosed in the ZENITH Global Phase X cardiovascular outcomes trial of Zilebesiran, marking progress in its clinical pipeline.
  
Most Critical Themes:
- Negative Sentiment on X: (20%) A significant portion of posts on X express negative sentiment, with users raising concerns about the company.
- FDA Crackdown and Ad Pull: (10%) Alnylam has withdrawn TV advertisements following regulatory action on drug industry advertising, which may lead to concerns.
  
  
  
### Social Dominance: XXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/social_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: XXXX%  
X Week: XXXXX% +0.018%  
X Month: XXXXX% -XXXXX%  
X Months: XXXXX% -XXXXX%  
X Year: XXXXX% -XXXXX%  
1-Year High: XXXXX% on 2025-01-23  
1-Year Low: XXXXXX% on 2025-12-07  
  
  
### Market Dominance: XXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/market_dominance.tsv)  
Current Value: XXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-09-09  
1-Year Low: XXXXX% on 2025-01-06  
  
  
### Market Cap: $XXXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:alnylam-pharmaceuticals-inc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/alnylam-pharmaceuticals-inc/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXXX -$12%  
X Month: $XXXXXXXXXXXXXX -$11%  
X Months: $XXXXXXXXXXXXXX +$30%  
X Year: $XXXXXXXXXXXXXX +$66%  
1-Year High: $XXXXXXXXXXXXXX on 2025-10-20  
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-08  

### Top Alnylam Pharmaceuticals, Inc. Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Six firms are set to join the Nasdaq XXX Index and six are set to leave as part of its annual reconstitution the benchmarks overseer said Friday. Alnylam Pharmaceuticals Inc. Ferrovial SE Insmed Incorporated Monolithic Power Systems Inc. Seagate Technology Holdings Plc and Western Digital Corp. will be included in the gauge prior to the market open on Dec. XX. Meanwhile the index will also see six subtractions: Biogen Inc. CDW Corporation GlobalFoundries Inc. Lululemon Athletica Inc. ON Semiconductor Corp. and The Trade Desk Inc. -Bloomberg $ALNY $FER $INSM $MPWR $STX $WDC $BIIB $CDW $GFS"  
[X Link](https://x.com/cdntradegrljenn/status/2000281772396097707) [@cdntradegrljenn](/creator/x/cdntradegrljenn) 2025-12-14T19:08Z 60.5K followers, 1114 engagements


"Buy Verified Cash App Accounts $ANIP $HROW $TEVA $PFE $BMY $LLY $ABBV $AMGN $JNJ $MRK $GILD $VRTX $BMRN $SRPT $ARWR $ALNY $IONS $BLUE $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $DNLI $FATE $SGMO $QURE $PGEN $DNLI $SLNO $BMRN $SRPT $ARWR $ALNY"  
[X Link](https://x.com/pinkie46749/status/2000252914858856543) [@pinkie46749](/creator/x/pinkie46749) 2025-12-14T17:13Z XX followers, X engagements


"$WDC $STX $ALNY $MPWR $FER $INSM Annual Changes to the Nasdaq100 Index The following six companies will be added to the Index: Alnylam Pharmaceuticals Inc. Ferrovial SE Insmed Incorporated Monolithic Power Systems Inc. Seagate Technology Holdings plc Western Digital Corp"  
[X Link](https://x.com/ApolloResearchC/status/2000247929269826017) [@ApolloResearchC](/creator/x/ApolloResearchC) 2025-12-14T16:54Z XXX followers, XXX engagements


"Second Round DONE Volatility Division Who had the best/worst Round X XX. @banquetsbetter $RKLB XX. @conorstonks $SOFI XX. @PMooreTrades $EOSE XX. @SPYCALLS25 $ABAT XX. @Ron_Trades $HROW XX. Drywater07 $ALNY XX. @JordanRube32165 $CIFR XX. aracypt $TQQQ XX. @LevinBurant $STCGF XX. Palatino6 $WM XX. future361 $CSCO XX. J $PATH"  
[X Link](https://x.com/fantstockleague/status/2000195439677542747) [@fantstockleague](/creator/x/fantstockleague) 2025-12-14T13:25Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Inc. (ALNY) added to Nasdaq XXX Index; company repurchases $XXXX million in convertible notes.

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on RNA interference (RNAi) therapeutics.
Alnylam Pharmaceuticals, Inc. uses the ticker $ALNY for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Alnylam Pharmaceuticals, Inc. (ALNY) trading volume is up XXXXX% from the previous week.
Alnylam Pharmaceuticals, Inc. (ALNY) social dominance is up XXXXXX% from the previous week.
Alnylam Pharmaceuticals, Inc. (ALNY) Galaxy Score™ is up XXXXXX% from the previous X months.
Alnylam Pharmaceuticals, Inc. (ALNY) engagements is up XXXXXX% from the previous week.

Price: $XXXXXX

Price 24-Hour Time-Series Raw Data
The stock price is experiencing volatility due to mixed news, with positive clinical trial data and strong sales being offset by regulatory concerns and negative social media sentiment, leading to a balanced outlook.

24-Hour: -XXXX% 7-Day: -XXXXX% 30-Day: -XXXXX%

1-Year High: $XXXXXX on 2025-10-20
1-Year Low: $XXXXXX on 2025-04-08

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Alnylam Pharmaceuticals, Inc. (ALNY) is currently AltRank #642 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XXX
X Month: XXX -XXX
X Months: XXX -XX
X Year: XXX -XXX
1-Year High: XXXXX on 2025-06-26
1-Year Low: X on 2025-03-22

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +44
X Month: XX +6
X Months: XX +4
X Year: XX -XX
1-Year High: XX on 2025-02-19
1-Year Low: XX on 2025-06-26

Engagements: XXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX +333%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +15%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-03-21
1-Year Low: XXX on 2025-12-07

Engagements by network (24h): TikTok: XXXXX X: XXXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX +7.40%
X Month: XXX -XX%
X Months: XXXXX +21%
X Year: XXXXX -XX%
1-Year High: XXX on 2025-08-13
1-Year Low: XX on 2025-12-07

Mentions by network (24h): TikTok: XX X: XXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Alnylam Pharmaceuticals, Inc. (ALNY) in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XXX
X Week: XXX +0.61%
X Month: XXX -XXXX%
X Months: XXXXX +106%
X Year: XXXXX +58%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-12-07

The most influential creators that mention Alnylam Pharmaceuticals, Inc. in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@BioBoyScout	X	XXXXX	X	XXX
@Andre_AGTC	X	XXXXX	X	XXX
@BiopharmIQ	X	XXXXXX	X	XXX
@RNAiAnalyst	X	XXXXXX	X	XX
@StockCompil	X	XXXXX	X	XX
@Biobeats99	X	XXX	X	XX
@ElliottForecast	X	XXXXXX	X	XX
@DanzTrader	X	XXXXX	X	XX
@USCorpFilings	X	XXXXX	X	XX
@MarcJacksonLA	XX	XXXXX	X	XX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% no change
X Month: XX% -X%
X Months: XX% +13%
X Year: XX% -X%
1-Year High: XXX% on 2025-07-29
1-Year Low: XX% on 2025-12-02

Most Supportive Themes:

Positive Data from HELIOS-B Study: (35%) New data from the HELIOS-B Phase X study shows reduced gastrointestinal events in ATTR-CM patients treated with Vutrisiran, supporting its use as a first-line therapy.
Amvuttra Sales and Revenue Guidance: (20%) Alnylam reported strong Amvuttra sales and increased its 2025 revenue guidance, indicating positive financial performance.
First Patient Dosed in ZENITH Trial: (15%) Alnylam announced the first patient has been dosed in the ZENITH Global Phase X cardiovascular outcomes trial of Zilebesiran, marking progress in its clinical pipeline.

Most Critical Themes:

Negative Sentiment on X: (20%) A significant portion of posts on X express negative sentiment, with users raising concerns about the company.
FDA Crackdown and Ad Pull: (10%) Alnylam has withdrawn TV advertisements following regulatory action on drug industry advertising, which may lead to concerns.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXX%
X Week: XXXXX% +0.018%
X Month: XXXXX% -XXXXX%
X Months: XXXXX% -XXXXX%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-01-23
1-Year Low: XXXXXX% on 2025-12-07

Market Dominance: XXXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-09-09
1-Year Low: XXXXX% on 2025-01-06

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX -$12%
X Month: $XXXXXXXXXXXXXX -$11%
X Months: $XXXXXXXXXXXXXX +$30%
X Year: $XXXXXXXXXXXXXX +$66%
1-Year High: $XXXXXXXXXXXXXX on 2025-10-20
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-08

Top Alnylam Pharmaceuticals, Inc. Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Six firms are set to join the Nasdaq XXX Index and six are set to leave as part of its annual reconstitution the benchmarks overseer said Friday. Alnylam Pharmaceuticals Inc. Ferrovial SE Insmed Incorporated Monolithic Power Systems Inc. Seagate Technology Holdings Plc and Western Digital Corp. will be included in the gauge prior to the market open on Dec. XX. Meanwhile the index will also see six subtractions: Biogen Inc. CDW Corporation GlobalFoundries Inc. Lululemon Athletica Inc. ON Semiconductor Corp. and The Trade Desk Inc. -Bloomberg $ALNY $FER $INSM $MPWR $STX $WDC $BIIB $CDW $GFS"
X Link @cdntradegrljenn 2025-12-14T19:08Z 60.5K followers, 1114 engagements

"Buy Verified Cash App Accounts $ANIP $HROW $TEVA $PFE $BMY $LLY $ABBV $AMGN $JNJ $MRK $GILD $VRTX $BMRN $SRPT $ARWR $ALNY $IONS $BLUE $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $DNLI $FATE $SGMO $QURE $PGEN $DNLI $SLNO $BMRN $SRPT $ARWR $ALNY"
X Link @pinkie46749 2025-12-14T17:13Z XX followers, X engagements

"$WDC $STX $ALNY $MPWR $FER $INSM Annual Changes to the Nasdaq100 Index The following six companies will be added to the Index: Alnylam Pharmaceuticals Inc. Ferrovial SE Insmed Incorporated Monolithic Power Systems Inc. Seagate Technology Holdings plc Western Digital Corp"
X Link @ApolloResearchC 2025-12-14T16:54Z XXX followers, XXX engagements

"Second Round DONE Volatility Division Who had the best/worst Round X XX. @banquetsbetter $RKLB XX. @conorstonks $SOFI XX. @PMooreTrades $EOSE XX. @SPYCALLS25 $ABAT XX. @Ron_Trades $HROW XX. Drywater07 $ALNY XX. @JordanRube32165 $CIFR XX. aracypt $TQQQ XX. @LevinBurant $STCGF XX. Palatino6 $WM XX. future361 $CSCO XX. J $PATH"
X Link @fantstockleague 2025-12-14T13:25Z XXX followers, XXX engagements